Your browser doesn't support javascript.
loading
Sexually Transmitted Infections Among Men and Transgender Women Using HIV Pre-exposure Prophylaxis in a Large Integrated Health System-A Cohort Study.
Hechter, Rulin C; Bruxvoort, Katia J; Zhou, Hui; Towner, William J; Contreras, Richard; Schumacher, Christina M; Grant, Deborah L; Jones, Joyce.
Afiliación
  • Hechter RC; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
  • Bruxvoort KJ; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA.
  • Zhou H; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
  • Towner WJ; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
  • Contreras R; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
  • Schumacher CM; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA.
  • Grant DL; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
  • Jones J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
J Acquir Immune Defic Syndr ; 91(1): 1-8, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35499561
ABSTRACT

BACKGROUND:

Sexually transmitted infections (STIs) are common in people using pre-exposure prophylaxis (PrEP). We examined risk and factors associated with STIs in a cohort of PrEP users in an integrated health system in the United States.

SETTING:

The Kaiser Permanente Southern California is a large integrated health system that provides comprehensive medical services to approximately 4.7 million demographically diverse members.

METHODS:

We identified men and transgender women initiating PrEP between January 1, 2014, and June 1, 2018, and followed through December 31, 2018. Demographic and clinical factors potentially associated with the risk of bacterial STIs during PrEP use were evaluated using Poisson regression models.

RESULTS:

Among 5042 individuals tested for STIs with 7198 person-years of follow-up, 1709 (33.9%) had at least one new STI. The estimated incidence of STIs was 48.3 per 100 person-years, and the most common STI was rectal chlamydia. Most repeat STIs (61.4%) occurred <180 days apart. In a multivariable analysis, an history of STIs in the prior 6 months through 7 days after the PrEP initiation was the most prominent risk factor of STIs during PrEP use (adjusted risk ratio 1.78, 95% confidence intervals 1.65 to 1.93). Other risk factors included younger age (<35 years), being Hispanic, and having a history of alcohol use disorder or drug use disorder.

CONCLUSIONS:

Quarterly STI testing and targeted intervention to mitigate STI risk are warranted for young and racial minority PrEP users, particularly for those with prior history of STIs and substance use disorders.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de Transmisión Sexual / Infecciones por VIH / Prestación Integrada de Atención de Salud / Personas Transgénero / Profilaxis Pre-Exposición / Minorías Sexuales y de Género Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de Transmisión Sexual / Infecciones por VIH / Prestación Integrada de Atención de Salud / Personas Transgénero / Profilaxis Pre-Exposición / Minorías Sexuales y de Género Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2022 Tipo del documento: Article País de afiliación: Canadá